Objectives: Though curative resection is expected in clinical (c-) stage IA/ pathological ( p-) stage IA non-small-cell lung cancer (NSCLC), recurrence can occur. The aim of this study was to analyze the recurrence-free survival (RFS) of patients with c-stage IA/p-stage IA NSCLC who underwent complete resection. Methods: This was a retrospective study of a prospective database from 2005 to 2009 in our institution. A total of 155 patients with NSCLC was staged and resected. Pathologic invasiveness and RFS were compared with clinical factors and radiographic findings, including the tumour dimensions obtained from the thin-section computed tomography (TS-CT) lung window image and the mediastinal window image, maximum standardized uptake values (maxSUV) from 18F-fluorodeoxyglucose positron emission tomography (PET) or PET/CT images, and serum carcinoembryonic antigen (CEA) levels. Using TS-CT images, the tumour shadow disappearance ratio (TDR) (%) was calculated using the following equation: (major tumour dimension on mediastinal image/ major tumour dimension on lung image) ×100. Results: The median follow-up time was 91 months. The 5-year overall survival (OS) rate was 95% and the RFS rate was 90%. On univariate analysis, males, smokers, high serum CEA levels (>5.0 ng/ml), maxSUV >3.0, tumour dimension >2 cm in either the pulmonary window image or the mediastinal window image, TDR <50%, and angiolymphatic invasion were associated with significantly worse survival. On multivariate analysis, only tumour dimension in the mediastinal window (P = 0.047; hazard ratio 1.150) and CEA level >5 ng/ml (P = 0.012; hazard ratio 1.446) were independent predictors of survival. Conclusions: The important predictors of prognosis in patients with c-stage IA/p-stage IA NSCLC comprise the combination of tumour size in the mediastinal window and the CEA level and each alone, and they should be considered before selecting therapeutic strategies. Disclosure: No significant relationships.
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